Device Connectivity Is Key To Health Care IT Revolution
Executive Summary
The ability to create and maintain a data stream of information that flows from medical devices into electronic health records (EHRs) is starting to become an important priority for some of the nation’s hospitals. The development is a natural outgrowth of the movement toward having a viable EHR for every patient, as well as the understanding that quality of care can be enhanced if those EHRs are fed the type of data that comes from devices such as ventilators, infusion pumps, anesthesia machines, and products that measure patient vital signs. That need is creating a new, niche market for companies that offer connectivity solutions, and at some point, these changes are predicted to alter the way hospitals choose which medical devices to purchase.
You may also be interested in...
Masimo Root Monitoring System Gains FDA Clearance
Masimo has gained FDA clearance for its Root Patient Monitoring Platform, a noninvasive, continuous monitoring platform with interoperability and technologies that have demonstrated improved patient safety and cost of care.
Wireless Revolution Attracts New Health Care Partners
While device manufacturers look for ways to utilize wireless technology to enhance the use of their products, a number of nontraditional health care partners are emerging as important players in the market. Firms such as Qualcomm, AT&T, and other telecommunication companies are working to establish an infrastructure that will make it easier and safer for patient data to flow from remote devices to caregivers. These technology firms have already established deals and partnerships with some manufacturers, and although there is still a lot of work that needs to be done, their presence in this market is an important step that could hasten the ongoing wireless health care revolution.
ACOs Get In Gear, Accelerating Biopharma’s Value Imperative
Pharmaceutical companies have been reluctant to discuss their accountable care organization strategies, but the 32 “Pioneer” ACOs created this year could impact the way pharma develops and commercializes its drugs, and their influence will be felt well beyond their current Medicare remit.